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ABSTRACT 
The paper reviews the current trends of toxicological testing of 
chemicals in the U.S.A. and the methods of data generation for risk 
assessment and regulatory purposes. The recent survey conducted by 
NASINRC revealed that only a small fraction of widely used chemicals 
have been tested toxicologically. In spite of developments inshort-term 
toxicological tests, psing non-mammalian test species continue to be 
indispensable. 
In evaluating carcinogenicity tests, the current approach is 
generally based on the assumption that there is not threshold. 
Under the regulation of the Toxic Substances Act 1977 (U.S.A.) 
the responsibility of providing toxicological data lies with the 
manufacturer. The National Toxicology Programme emerged as a new 
governmental agency for toxicological evaluation since 1978 integrating 
a number of pre-existing testing activities in U.S.A. A number of 
private testing laboratories which can provide test data on contract 
basis also have come into existence in U.S.A. The guidelines published 
for risk assessment by the Environmental Protection Agency is expected 
to provide standards for the conduct of toxicological tests used for 
regulatory purposes. The newly formed Board -on Environmental 
Studies and Toxicology review9 and evaluates the toxicological issues. 
1. INTRODUCTION 
The toxicological testing of chemicals in the U.S. has expanded greatly in the 
last two decades, largely as a result of legislation requiring such testing for the 
protection of human health and the environment. The resources availabte for the 
development, analysis, and compilation of toxicological data also have expanded 
correspondingly. 
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2. TOXICOLOGY AND EPIDEMIOLOGY 
A major objective of toxicological evaluation is to predict the probable health 
(or ecological) effects of a chemical in advance, so that appropriate controls can be 
instituted (or substitutes found) in time to prevent undue human exposure and resulting 
injury. With the successful application of this approach through toxicological testing, 
epidemiological studies should, in principle, no longer be necessary as a means of 
identifying toxic' substances, although they will remain important in the follow-up of 
control measures to confirm that the intended purpose of preventing injury has been 
fulfilled. The relative strengths and weaknesses of toxicology, as compared with 
epidemiology, are largely self evident (Table 1)' and need no further discussion herein. 
Table 1. Some attributes of toxicology and epidemiology : comparitive strengths and limitations (from 
reference I) .  
Attribute or Toxicology Epidemiology 
Application 
Relevancy Uncertain Excellent 
Control of variables : 
Exposure, 
Environment, 
Confounding factors 
Identifying 
casual factors 
Size of population 
Sensitivity 
Genetic diversity 
Intercurrent disease 
Study of mechanisms 
Diagnostic tests 
Excellent Poor 
Excellent Poor 
Limited Can be very large 
Poor Poor 
Normally deliberately narrow Broad 
Controllable Not controllable 
Easily accessible Ethical hindrances 
Uncertain relevancy Directly relevant 
Unrestricted Severely restricted 
(except interview) 
3. THE EXTENT OF THE NEED FOR TOXICOLOGICAL DATA 
The U.S. National Academy of SciencesINational Research Council (NASINRC) 
recently conducted a major survey of the extent and quality of testing of chemicals 
in current use.2 For logistical reasons, the survey was limited to machine-retrievable 
lists of chemicals, which comprised a 'universe' of some 65,000 entries (53,500 discrete 
molecular entities). The chemicals were classified into 7 categories according to use 
or production volume, including pesticides, food additives, drugs, rosmetics, and 
chemiqals pf commerce, and were then examined by an appropriate stratified sampling 
technique. Representative substances in each category were evaluated as to the 
percentages tested and the thoroughness and quality of the tests. 
Among the substances in different categories, drugs and medicinal products were 
found to be the most extensively tested, followed by pesticides (Fig. 1). These 
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SIZE OF ESTIMATED MEAN PERCENT 
CATEGORY CATEGORY IN THE SELECT UNIVERSE -- 
PESTICIDES AND INERT 3.m 
INGREDIENTS OF PESTICIDE 
FORMULATIONS 
COSMETIC N G R W N T S  3.4 10 
DRUGS AND EXCIPIENTS 
USED I DRUO 
FORMOLATONS 1,815 
FOOD ADDITIVES 8,627 5 141  34 46 
...... CHEMICALS IN COMMERCE : ...... 
...... AT LEAST ONE MLLlON , *, 860 ...... 1 
POUNDS / YEAR I1 I\ 78 
CHEMICALS N COMMERCE : 
LESS THAN ONE MLLlON 13, 
POU(DS/VEAH 12 I2 76 
...... 
CHEMICALS IN COMMERCE : ...... 
OR MACCESSiSLE 82 
COMPLETE PARTIAL,' MINIMAL SOME NO TOXICITY 
I-EALTH HEALTH TOXICITY TOXICITY INFORMATION 
HAZARD HAZARD INFORMATION WORMATION AVAILABLE 
ASSESSMENT ASSESSMENT AVAILABLE AVAILABLE 
POSSIBLE POSSIBLE (But bdow Minimal) 
Figure 1. Availability and adequacy of toxicological data for chemicals within different use and production 
categories (reproduced from ref.2). 
differences, reflect the relatively strict and long-standing legal requirements for the 
testing of pesticides and drugs. 
Although more than 60 per cent of pesticides were found to have had some 
degree of toxicological evaluation, only about 10 per cent were deemed to have been 
evaluated with sufficient thoroughness to enable a complete assessment of their risks 
to health (Fig. 1). Of the total 'universe' of 65,000 entries, more than 40,000 of the 
chemicals were in large-scale commercial use, and these were found to havk had very 
limited testing; in fact, there were none for which the data were ,deemed adequate to 
enable a complete health hazard assessment (Fig. 1). Hence, despite much public 
concern and the development of elaborate testing resources in the United States, only 
a small fraction of chemicals to which there is widespread human exposure have been 
tested toxicologically in a way that would be considered adequate. 
4. CURRENT TRENDS IN TOXICITY TESTING 
4.1 Types of Tests 
Toxicity testing in the U.S., as elsewhere, depends largely on the use of laboratory 
animals.'There has been considerable pressure to develop test systems for replacing 
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mammals with non-mammalian test species and with short-term isolated test systems, 
but success in the development of such systems has been modest thus far. Nevertheless, 
these approaches are being actively explored. 
A short-term, non-mammalian test that has enjoyed considerable success is, of 
course, the bacterial reverse mutation assay system, as developed by Ames and other 
 worker^.^ This system has provided toxicologists with an efficient and informative 
technique for studying the genetic toxicity of chemicals and has achieved an important 
.role in the screening of chemicals for potential carcinogenicity. Nevertheless, it'is not 
regarded by most workers as capable of replacing long-term animal tests. A recent 
review under the auspices of the International Programme on Chemical Safety 
(IPCS)~, which systematically examined a battery of short-term tests for carcinogenicity 
and mutagenicity, concluded that some supplementation of the Ames Test is necessary 
to satisfy even the initial steps of testing for carcinogenicity. This lPCS document, 
summarizing a worldwide study of short-term tests for ca~cinogenicity, concluded that 
among the various assays investigated the induction of chromosomal aberrations, cell 
transformation, gene mutation in mammalian cells, and aneuploidy in yeast gave 
encouraging results when used to supplement the bacterial reversion test system. 
Thus, although considerable progress has been made with the powerful new short-term 
tests which have become available for examining the toxicity of chemicals, the definitive 
test for carcinogenicity still remains the lifetime bioassay in rodents. 
A recent study of the Scientific Group on Methodologies for the Safety Evaluation 
of chemicals5 examined the possible availability of short-term tests for evaluating 
other types of chemical toxicity to various organ systems (skin, liver, lung, immune 
system, hemopoietic system, etc.). The general conclusion of this study was that no 
short-term tests f o i  overall organ toxicity are available as yet, although there exist 
many tests for specific toxic endpoints, 
Accordingly, the use of classical animal tests still remains the definitive basis for 
the most toxicological evaluations. These tests involve exposure of animals by 
ingestion, inhalation, skin application, or other means, with subsequent observation 
for adverse effects. The tests'are being constantly expanded and improved, and now 
include many more refined biochemical and functional tests than have been available 
heretofore. 
A limitation in current procedures, as in past procedures, is the uncertain reliability 
of extrapolation among different species and among different levels of dose. It is 
generally recognized that apptopriate allowance for pharmacokinetic differences can 
markedly improve the extrapolation from a test animal species to humans. Hence use 
of pharmacokinetic data has become more or  less routine in the studies of the National 
Toxicolo~y Programme (NTP), discussed elsewhere in this report. 
For practical reasons, the procedures currently in use in toxicity testing involve 
the exposure primarily of rats and mice. It appears that in recent decades, there has 
been a decrease in the use of primates and other large animals, such as dogs and 
rabbits, in toxicity testing within the U.S. 
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There has been a growing refinement in environmental controls along with other 
advances in testing procedures. The use of inbred animals and their maintenance in 
pathogen-free circumstances has become routine. As concerns the number of animals 
per test group, group sizes have tended to become larger in recent years; i.e., in the 
standard NTP bioassay, there are 50-60 animals of each species and sex per dose 
group. A carcinogenicity study camed out at the National Centre for Toxicological 
Research several years ago (the so-called ED01 study)6, which aimed at identifying 
increases in cancer incidence at the 1 per cent level, required such large test groups 
(of the order of 2,000-3,000 mice per group) that a study of its type is not likely to 
be repeated in the near future. 
Although a two-year, or lifetime, rodent study is regarded as imperative for the 
detection of carcinogenicity, there is a growing body of opinion that a 90day study 
may be adequate for the detection of most other forms of systemic toxicity, including 
reproductive injury. For detection of the overall effects of chemicals on reproduction, 
however, multi-generation studies are customary; a newer and somewhat more efficient 
alternative for this purpose is the fertility assessment by continuous breeding assay 
system7, which is being explored by NTP. 
4.2 Interpretation and Application of the Data 
Until 30 years ago, it was generally assumed that there was a 'threshold' below 
which chemicals could be considered 'safe'. With further understanding of the mode 
of action of carcinogens, this concept has since given way to the assumption, for public 
health purposes, that carcinogens operate without threshold and hence'that any level 
of exposure to a carcinogen may conceivably produce some risk of a malignant lesion. 
The threshold concept is still in extensive use for many other toxic endpoints, 
however, with the result that the relevant evaluation procedures are still based on 
the so-called no observed effect level (NOEL) in test animals. This level, determined 
experimentally, is decreased by a safety factor - often 100 (10 for species differences 
and 10 to allow for uncertainty or human variability) - to arrive at an estimate of the 
threshold for the human population and to determine 'acceptable' levels from which 
allowable daily intakes (ADI), maximum allowable concentrations (MAC), and 
threshold limit values (TLV) can be derived. 
With the abandonment of the threshold hypothesis for carcinogenicity, the NOEL 
approach for assessing the risks of carcinogens has been supplanted in the U.S.A. by 
the use of quantitative risk assessment.' Although quantitative risk assessment had 
been applied previously to prediction of the carcinogenic effects of low-level ionizing 
radiation, it was a new approach for evaluating the toxicity of chemicals. The rationale 
for the approach was based on the premise that a dose-response curve for a given 
chemical could be derived from epidemiological data or animal test results that would 
enable prediction of the risk of carcinogenicity following exposure to the chemical at 
low doses (Fig. 2).9 Parenthetically, it should be noted that some workers have 
continued to challenge the applicability of the 'no threshold' concept to chemicals 
that are not genotoxic as determined, for example, by the Ames Test. 
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Dose 
Figure 2. Simplified diagram of representative hypothetical doe-response relationships for carcinogens 
(reproduced from ref.9). 
As mentioned above, the relatively small number of animals that can feasibly 
be used in carcinogenicity tests have only limited capability for detecting the low rates 
of response that would be socially acceptable in human populations. Because high 
test doses must be used in order to produce detectable rates of response, extrapolation 
of the results to far Iower doses is required in order to assess the risks at dose levels 
relevant to human exposure. The extrapolatipn model selected for this purpose has 
a major influence on the predicted dose-response relationship and hence on the 
estimate of risk at low levels of exposure (Table 2).1° Although the models used in 
the past have varied widely, there has been a tendency to ~oncentrate~increasingly 
on the Doll and Armitage tnodell', which is thought to have greater biological validity 
than others. This model, when used as the basis for extrapolation, has been adapted 
to force linearity near the zero dose intercept. 
Table 2. Ex6rapolated values of 'safe' doses, as estimsted with three different dose-response models, each 
of which conforms equally well to the responses observed In the 2 to 50% response range (from reference 10). 
Probit Logistic One-particle 
curve curve curve 
In addition to extrapolating from. high dose levels to lower dose levels in 
interpreting toxicological test data for purposes of risk assessment, it is also necessary 
to extrapolate from the test animal to man. There is always uncertainty, howevei, as 
to how faithfully the response of any other animal species parailels the human response. 
Concern about this problem has led to the conviction that pharmacokinetic studies 
should be used more fully in toxicological evaluations1*, with the result that such 
studies are now a standard part of toxicity testing in the NTP. 
Generation of Toxicological Data on Chemicals 91 
The application, by regulators, of mathematical models relating cancer incidence 
to dose has varied from time to time and from agent to agent. Thus, the level of 
exposure that has been estimated to correspond to an acceptable level of risk has 
varied, depending on the particular regulatory application. Furthermore, the estimate 
has usually been based on a 'risk-vs-benefit' decision, rather than on a purely scientific 
judgement. Hence, the lifetime risks of cancer judged to be acceptable have ranged 
from 1 in 1000 (occasionally higher) down to 1 in a million exposed persons. 
In recent years, it has become customary to distinguish between: (i) the estimation 
of risk - qualitative as well as quantitative - which is regarded as a largely scientific 
and value-free process (although risk estimates are.in some degree value-laden, 
depending on the assumptions going into the calculations) and (ii) the application of 
the resulting risk estimate t o  a specific regulatory problem. This distinction has been 
discussed in a recent NASMRC report", which suggests that the first step, 'risk 
assessment', is essentially a scientific endeavor, whereas the second step, 'risk 
management' (that is, the application of risk assessment to a specific control or 
regulatory problem) entails consideration of various socio-political and philosophical 
issues (e.g., determining the level of risk that the public is willing to accept for the 
benefits secured). 'Risk management' is thus regarded as a trans-scientific matter, 
with the result that some agencies meticulously separate it from "risk assessmeot", 
as a second and distinct step. 
5. RESPONSIBILITY FOR GENERATING THE DATA 
In the regulation of many chemicals in the U.S.A., it has long been held that 
the manufacturer of a substance ordinarily has the responsibilty to prove that no harm 
will arise from its proposed use. Thus, the manufacturer of a chemical intended as a 
food additive must supply toxicological data demonstrating the safety of the substance 
under the proposed pattern of use. It is noteworthy in this context that the food 
regulations in the U.S.A. contain the Delaney Clause, which stipulates that a chemical 
known to cause cancer in man or animals may not be used as deliberate food additive. 
Pesticides, however, which may be inadvertent contaminants in food commodities, 
are not specifically covered by the Delanejl Clause unless they concentrate in processed 
food. In the regulation of raw food commodities, Environmental Protection Agency 
(EPA) has used the quantitative risk assessment approach for evaluating pesticides, 
rather than an all-or-none approach, so as not to exclude pesticides which are important 
in the maintenance of the food supply or in agricultural practice. The pesticide 
manufacturer is expected to supply the appropriate data for such calculations. 
Under the Toxic Substances Control Act (TSCA) of 197714, the manufacturers 
of chemicals newly going into commerce are required to notify EPA and to supply 
data bearing on the toxicity of their proposed products. The burden of evidence 
requiring additional data rests on EPA, so that a decision by the Agency to permit 
a manufacturer to proceed may depend on little more than evaluation of 
structure-activity relationships. Nevertheless, EPA can find that because of possible 
widespread exposure or potential unreasonable risk, the submission of additional data 
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may be required; on the basis of this it can deny permission to manufacture a new 
chemical. The manufacturer of a chemical may also be required to submit additional 
toxicity data *as production of the chemical proceeds. 
6. PERFORMERS OF TOXICOLOGIC STUDIES 
For 'old' chemicals, which are not on the TSCA 'inventory', there is no established 
requirement for toxicity testing. Some of the needs for testing of these chemicals are 
now being met by the NTP. The Chemical Industry Institute of Toxicology (CIIT) 
tests some agents in the general domain; for example, formaldehyde. 
Over the last two decades, there has been a major shift in the extent of toxicological 
testing and in the mechanisms by which toxicological data are developed in the U.S.-A. 
Only a few chkmical manufacturers had established substantial toxicological testing 
laboratories before World War 11; e.g., Dupont, Dow, and Union Carbide, and these 
continue to be active. More recently, a number of other manufacturers also have 
developed extensive testing facilities, but their course has been variable. With the 
increased requirement 'for toxicological test data imposed by stricter regulatory 
controls, however, that has developed a substantial industry of testing laboratories, 
which provide test data under contract. More than 280 such contract laboratories are 
now estimated to exist, with approximately 16,000 employees in total and an annual 
revenue of more than 450 million do~lars. '~ 
The Food and Drug Administration (FDA) has, tested chemicals in order to 
examine the potential toxicity of substances in the public domain or, occasionally, to 
supplement toxicological data supplied by manufacturers. The National Centre for 
Toxicological Research (NCTR), which is operated by the FDA and located in 
Arkansas, is a relatively new entry into the toxicological field. NCTR does some 
testing, but it is more concerned with fundamental toxicological research. 
A more recent entry into the field is the NTP, which was established in 1978. 
This Programme brought together and integrated a number of pre-existing testing 
activities at the National Cancer Institute (NCI), NCTR, the National Institute of 
Environmental Health Sciences (NIEHS), and the National Institute for Occupational 
Safety and Health (NIOSH). This included the large-scale carcinogenicity bioassay 
programme under the NCI, which was transferred to the NIEHS in 1981. The NTP . 
also has affiliations with the FDA, the Occupational Safety and Health Administration 
(OSHA), the EPA, the.Consumer Product Safety Commission (CPSC), and other 
federal agencies. The NTP conducts substantial testing activities, in cooperation with 
the three participating agencies, particularly NIEHS. The Director of the NTP, who 
reports directly to the Assistant Secretary of Health, is at present also Director of 
NIEHS. The latter arrangement is not obligatory, but it is fortunate in providing NTP 
direct access to the extensive research resources of NIEHS. The NTP undertakes a 
full range of toxicity studies for end-points of many kinds, including carcinogenic 
effects, disorders of the liver, lung, and kidney, reproductive disabilities, 
immunological defects, etc. It also conducts an extensive array of short-term tests. 
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During the current year the NlT will complete and have peer reviewed some 
25 lifetime bioassays (approximately 350 t o  date, including NCI and NTP) for 
carcinogenicity. Its bacterial reversion (Ames) tests approximate 200 annually (some 
1,300 to date).'' Typical protocols for 2-year tests are illustrated1' in Table 3. ' 
Table 3. Representative design features of long-turn (byear )  toxkdogy and cardnogenesis shwlks as 
performed by NTP (from reference 17). 
Animals : Fischer 344N rats and B6C3Fi mice 
Sex : Males and females 
Group size : 60 animals/grouplspecies/sex/dose 
Number of groupd : Control and 2-4 exposure groups/species/sex 
Doses : Chosen as proportions (typically 0,0.25,0.50, and 1.0) of an estimated maximally 
tolerated dose (EMTD), based on biochemical, toxicologic, and histopatho- - 
logic observations from prechronic studies (90-120 day exposures). 
Duration : 104 weeks (-2/3 life span) 
Interim sacrifice times : at 15 andlor 18 months (10 animals/group/species/sex/dose) 
Necropsy : All animals, 
Diagnoses : Three-phase histopathology process. 
Normally, the NTP studies ~ e r ~ p r e c e d e d  by a series of associated shorter studies 
which aid in dose selection, particularly the estimated maximally tolerated dose 
(MTD).'~ However, an important objective of these associated tests is to develop a 
broad assessment of the general toxicity of the chemicals examined. Included is an 
array of genetic toxicity studies; for example, gene mutations in bacteria and 
mammalian cells, chromosome alterations, transformation, DNA damage and repair, 
fertility and reproductive assessment (sperm morphology and vaginal cytology), 
teratology tests, systemic toxicity (14,90 and 120 day exposures), clinical pathology, 
hematology, biochemistry, and urine-analysis. Also included for most chemicals is a 
systematic pharmacokinetic study.I6 Thus, in addition to the assessment of 
carcinogenicity, the program provides a broad, general toxicologic appraisal of the 
chemicals studied. Multigeneration studies in rodents continue to be used; however, 
NTP i s  exploring several alternatives (for example, the fertility assessment by 
continuous breeding assay system7) in searching for more efficient and informative 
tests. 
The NTP thus constitutes a major resource of the federal establishment for the 
full-scale toxicological evaluation of chemicals. It operates under an Executive 
Committee made up of the heads of major components of NIH and CDC and the 
heads of major federal regulatory agencies. General guidance of the scientific 
programme is under an external Board of Scientific Counsellors, the meetings of 
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which are open to the public. The Board also is involved in the review of chemicals 
which are recommended for testing by NTP, and it oversees review of the reports 
which are produced under NTP auspices. 
The Consumer Product Safety Commission (CPSC) has no in-house toxicological 
resources but supports. gtants and contracts to examine toxicological issues in its 
domain of responsibility. 
The NIOSH is responsible for substantial research on occupational hazards, 
including toxicological as well as epidemiological studies. Among its responsibilities 
is the provision of data underlying the establjshment of Permissable Exposure Levels 
(PEL's) by the OSHA. NIOSH's contribution to this task, however, has been limited 
thus far. The major source of information leading to PEL's has come from an activity 
conducted for many years by an independent professional society, the American 
Conference of Governmental Industrial Hygienists (ACGIH). This committee has 
been responsible for the establishment of most of the TLV's currently in use in the 
U.S.A., many of which have been incorporated into regulations as PEL's pending 
their replacement by new standards proposed to OSHA by NIOSH. 
The Department of Defence obtains toxicological information from many of the 
above-mentioned governmental testing agencies. Also, through the Army, it maintains 
an environmental health laboratory at Edgewood, Maryland, which has been active 
in toxicological, work for a number of years. 
EPA has a large research programme which is extensive in its coverage; however, 
it deals primarily with generic issues pertinent to toxicity testing rather than with the 
testing of specific chemicals themselves. The research conducted in EPA is under the 
general policy oversight of the Science Advisory Board, which is made up of a number 
of specialized sub-sections, including health, air pollution, engineering, ecology, etc. 
Deliberations of the Board's advisory groups are open to the public. 
EPA has recently published guidelines for risk assessment relating to the 
interpretation of a variety of toticological tests, including tests for carcinogenic effects, 
tests for studying the effects of mixtures of chemicals, tests for developmental 
disturbances, methods for the estimation of exposure, etc. The guidelines are intended 
to provide basic standards for the conduct of toxicological tests used for regulatory 
purposes. 
Substantial research on the basic aspects of chemical toxicology is conducted in 
NIEHS, which has an extensive intramural programme devoted to research on the 
basic mechanisms of action of foreign chemicals. In addition, it supports an extensive 
extramural programme of university-based toxicological research. Included in this 
programme are some 10 centres of excellence in distinguished universities throughout 
the nation, which are committed to long-term research on toxicological problems, 
including relevant epidemiological studies. These centers thus provide a cadre of 
career-oriented scientists working at the interface between basic science and 
toxicology, thus advancing our understanding of the basic mechanisms of chemical 
injury. Proposals for future research directions for NIEHS have recently been 
published. '" 
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7. REVIEW AND EVALUATION OF TOXICOLOGICAL ISSUES 
A major wsource in the U.S.A. for the review of toxicological problem exists 
in an organization within the NASMRC, which has been known until recently as the, 
Board on Toxicology and Environmental Health Hazards. The Board has recently 
merged with the Environmental Studies Board and is now identified as the Board on 
Environmental Studies and Toxicology (BEST). It's reviews, some of which are 
self-initiated, often arise through specific governmental requests from Congress or 
federal agencies and are conducted by special or standiqg committees, which include 
the Committee on Toxicology. The Board also maintains a Toxicology Information 
Centre, which is available as a resource, particuiarly to federal agencies, for 
consultation on emergency exposure guidelines or fy'other special studies as required. 
The Centre can, under special circumstances, provide rapid consultation on possible 
toxicological problems, which can later be given more deliberate review by the 
Committee on Toxicology. 
Within the Department of Defence, there exists the Armed Forces 
Eoidemiological Board (AFEB), which was organized in World War 11. The Board 
was formed primarily for advice to the militaiy on infectious diseases, but its mission 
quickly became expanded to cover advice on other environmental hazards, including 
chemicals. It continues to give such-advice 'at the present time. 
8. INFORMATION SOURCES 
A number of information sources are available in the field sf toxicology. Important 
sources maintained by the Nationabibraq of-Medicine are ToxLine and its allied 
compilations. These are availa6le to any instittition having t6e appropriate computer 
linkage.19 In addition, there is an Annual Report onGarcinogens, which is published 
by NTP." i 
Finally, there has been a remarkable proliferation of journals published in the 
field of toxicology, not only in the United States but in other countries as well. These 
periodicals provide an abundant and growing resource for publication of toxicological 
research reports and reviews. The numbers of toxicological studies reported in other 
biomedical journals also has increased substantially and continues to grow. 
It can be said that extensive resources for generating toxicological data exist in 
the U.S.A. Furthermore, the elaborate resources, that have been developed over the 
last 20 years are a reflection of public pressures on the U.S. Congress and other 
agencies in the federal government for closer scrutiny of possible chemical injury to 
health and the environment. Indeed, public interest in this subject continues unabated, 
as shown by recent opinion polls. The aggregate expenditure on testing resources 
nationwide, as noted above, can be estimated now to exceed some 450 million dollars 
in contract laboratories alone; however, this sum represents only a small fraction of 
the total value of shipments in the chemical industry in the United States, which is 
on the order of $160 billion2', exclusive of drugs, soaps, and toi~etries.~' 
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The U.S.A. does not stand alone, of course, in the expansion of toxicological 
activities; most industrialized countries (and growing numbers of developing countries) 
also now have extensive resources. In parallel with these developments, WHO has 
responded by establishing the International Programme on Chemical Safety (with 
UNEP and ILO) and the International Agency for Research on Cancer; UNEP has 
established the International Register of Potentially Toxic Chemicals. 
In short, the widespread demand for the benefits of a flourishing chemical 
technology have prompted the development of toxicological resources for purposes 
of assuring that the technology can be operated with prudent safeguards. 
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